Perhaps because the function of the activin signaling pathway in pancreatic tumor development and progression is complex and context-dependent, the genetic alterations in the activin signaling pathway do not significantly correlate with survival in PDAC patients (Figure 2C). This evidence concerns the gene INHBE and pancreatic neoplasm.